Profundizar
Referencias bibliográficas |
| Casadevall A, AL Rosas y JD Nosanchuk. 2000. Melanin and virulence in Cryptococcus neoformans. Curr. Opin. Microbiol. 3:354–358.Espinel-Ingroff A. 1998. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol. 36:198–202.Ikeda R, T Sugita, ES Jacobson, T Shinoda. 2003. Effects of melanin upon susceptibility of Cryptococcus to antifungals. Microbiol. Immunol. 47: 271–277.McFadden DC, A Casadevall. 2001. Capsule and melanin synthesis in Cryptococcus neoformans. Med. Mycol. 39:19–30.Johnson LB, CA Kauffman. 2003. Voriconazole: a new triazole antifungal agent. Clin. Infect. Dis. 36:630–637.McGinnis MR, L Pasarell, DA Sutton, AW Fothergill, CR Cooper Jr, MG Rinaldi. 1997. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob. Agents Chemother. 41:1832–1834.Van Duin D, A Casadevall, JD Nosanchuk. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibility to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46:3394–3400. |
| Otros artículos de Oscar Zaragoza |
| Zaragoza O, Taborda C, Casadevall A. (2003) The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the localization of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur. J. Immunol. 33:1957-67.Zaragoza O, Fries BC, Casadevall A. (2003) Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO2. Infect. Immun. 71:6155-64.Zaragoza O, Casadevall A. (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proc. Online. 6:10-15.Van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. (2004) Effects of vorinazol on Cryptococcus neoformans. Antimicrob. Agents. Chemother. 48:2014-20.McFadden DC, Zaragoza O, Casadevall A. (2004) Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum. J. Clin. Microbiol. 42:2786-8.Zaragoza O, Casadevall A. (2004) Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies. Infect. Immun. 72:4271-4. |
